Search Results - "Yu, Jiehai"

Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer by Sui, Qiaoqi, Zhang, Xi, Chen, Chao, Tang, Jinghua, Yu, Jiehai, Li, Weihao, Han, Kai, Jiang, Wu, Liao, Leen, Kong, Lingheng, Li, Yuan, Hou, Zhenlin, Zhou, Chi, Zhang, Chenzhi, Zhang, Linjie, Xiao, Binyi, Mei, Weijian, Xu, Yanbo, Qin, Jiayi, Zheng, Jian, Pan, Zhizhong, Ding, Pei-Rong

“…Inflammation is a common medical complication in colorectal cancer (CRC) patients, which plays significant roles in tumor progression and immunosuppression…”
Get full text

Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer by Qin, Youwen, Tong, Xin, Mei, Wei-Jian, Cheng, Yanshuang, Zou, Yuanqiang, Han, Kai, Yu, Jiehai, Jie, Zhuye, Zhang, Tao, Zhu, Shida, Jin, Xin, Wang, Jian, Yang, Huanming, Xu, Xun, Zhong, Huanzi, Xiao, Liang, Ding, Pei-Rong

“…The incidence of young-onset colorectal cancer (yCRC) has been increasing in recent decades, but little is known about the gut microbiome of these patients…”
Get full text

The effects of oxaliplatin-based adjuvant chemotherapy in high-risk stage II colon cancer with mismatch repair-deficient: a retrospective study by Liao, Leen, Tang, Jinghua, Hong, Zhigang, Jiang, Wu, Li, Yuan, Kong, Lingheng, Han, Kai, Hou, Zhenlin, Zhang, Chenzhi, Zhou, Chi, Zhang, Linjie, Sui, Qiaoqi, Xiao, Binyi, Mei, Weijian, Yu, Jiehai, Yang, Wanjun, Pan, Zhizhong, Ding, Pei-Rong

“…For high-risk stageIImismatch repair deficient (dMMR) colon cancers, the benefit of adjuvant chemotherapy remains debatable. The principal aim of this study…”
Get full text

Locally advanced rectal cancer with dMMR/MSI-H may be excused from surgery after neoadjuvant anti-PD-1 monotherapy: a multiple-center, cohort study by Yang, Renfang, Wu, Tao, Yu, Jiehai, Cai, Xinyi, Li, Guoyu, Li, Xiangshu, Huang, Weixin, Zhang, Ya, Wang, Yuqin, Yang, Xudong, Ren, Yongping, Hu, Ruixi, Feng, Qing, Ding, Peirong, Zhang, Xuan, Li, Yunfeng

“…Examine patients with locally advanced rectal cancer (LARC) with deficient mismatch repair (dMMR) or microsatellite instability-high (MSI-H) who received…”
Get full text

Correction: Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer by Dong, Peixin, Xiong, Ying, Yu, Jiehai, Chen, Lin, Tao, Tang, Yi, Song, Hanley, Sharon J. B., Yue, Junming, Watari, Hidemichi, Sakuragi, Noriaki

“…In Fig. 2d, the Western blot panels representing GAPDH endogenous loading controls were improperly cropped, leading to four lanes of GAPDH endogenous loading…”
Get full text

Control of PD-L1 expression by miR-140/142/340/383 and oncogenic activation of the OCT4–miR-18a pathway in cervical cancer by Dong, Peixin, Xiong, Ying, Yu, Jiehai, Chen, Lin, Tao, Tang, Yi, Song, Hanley, Sharon J. B., Yue, Junming, Watari, Hidemichi, Sakuragi, Noriaki

“…PD-L1, a key inhibitory immune receptor, has crucial functions in cancer immune evasion, but whether PD-L1 promotes the malignant properties of cervical cancer…”
Get full text

Nonoperative Management of dMMR/MSI-H Colorectal Cancer following Neoadjuvant Immunotherapy: A Narrative Review by Xiao, Binyi, Yu, Jiehai, Ding, Pei-Rong

“…Immunotherapy with PD-1 blockade has achieved a great success in colorectal cancers (CRCs) with high microsatellite instability (MSI-H) and deficient mismatch…”
Get full text

Screening and Management of Lynch Syndrome: The Chinese Experience by Yu, Jiehai, Ding, Pei-Rong, Jiang, Wu

“…Lynch syndrome (LS), caused by germline mutations in the mismatch repair genes, is the most common hereditary colorectal cancer. While LS is also associated…”
Get full text

Safety and effectiveness of subtotal pelvic peritonectomy for patients with colorectal cancer with limited peritoneal metastasis in pelvic cavity by Liao, Leen, Tang, Jinghua, Xiao, Binyi, Jiang, Wu, Han, Kai, Kong, Ling-Heng, Yu, Jiehai, Pan, Zhi-Zhong, Ding, Pei-Rong

“…e15587 Background: Cytoreductive surgery with extensive visceral resection and peritonectomy has shown long-term survival benefits for colorectal cancer (CRC)…”
Get full text

Efficacy of PD-1 inhibitors for colorectal cancer and polyps in patients with Lynch syndrome by Yu, Jiehai, Xiao, Binyi, Tang, Jinghua, Li, Dandan, Wang, Fang, Ding, Ya, Han, Kai, Kong, Ling-Heng, Ling, Yi-hong, Mei, Wei-Jian, Hong, Zhigang, Liao, Leen, Yang, Wanjun, Pan, Zhi-Zhong, Zhang, Xiao-Shi, Jiang, Wu, Ding, Pei-Rong

“…e15521 Background: Programmed death-1 (PD-1) inhibitor is effective for colorectal cancer (CRC) with deficient mismatch repair (dMMR) or high microsatellite…”
Get full text

DNA ploidy and stroma predicted the risk of recurrence in low-risk stage III colorectal cancer by Li, Yuan, Liao, Leen, Kong, Lingheng, Jiang, Wu, Tang, Jinghua, Han, Kai, Hou, Zhenlin, Zhang, Chenzhi, Zhou, Chi, Zhang, Linjie, Sui, Qiaoqi, Xiao, Binyi, Mei, Weijian, Xu, Yanbo, Yu, Jiehai, Hong, Zhigang, Pan, Zhizhong, Ding, Peirong

“…Background For clinically low-risk stage III colorectal cancer, the decision on cycles of adjuvant chemotherapy after surgery is disputed. The present study…”
Get full text